Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) healthcare behemoth. Medtronic has increased its dividend for 47 ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

Medtronic (MDT) is a billion-dollar global leader in medical technology, offering medical devices and therapies to more than 74 million people across 150+ countries. Medtronic—derived from ...

Medtronic first brought its lawsuit against Axonics to the Central California district court in late 2019 though the trial had been paused as the two companies danced over the validity of the ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical ...

Principle physician education specialist Jakub David and principle mapping specialist Tim Sorrell Jr. perform a training exercise with the Affera Mapping and Ablation System with Sphere-9 Catheter ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...